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SCIENTIFIC OPINION 
Scientific Opinion on an application (Reference EFSA-GMO-NL-2011-100) 
for the placing on the market of the herbicide-tolerant, increased oleic acid 
genetically modified soybean MON 87705 × MON 89788 for food and feed 
uses, import and processing under Regulation (EC) No 1829/2003 from 
Monsanto
1
 
EFSA Panel on Genetically Modified Organisms (GMO)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The EFSA GMO Panel previously assessed the two single events combined to produce soybean MON 
87705 × MON 89788 and did not identify safety concerns. No new data on the single events affecting the 
previous conclusions were identified. No differences in composition requiring further assessment were observed 
between soybean MON 87705 × MON 89788 and its comparator, except for the intended trait i.e. an altered fatty 
acid profile. Nutritional assessment on soybean MON 87705 × MON 89788 oil and oil-containing food products 
did not identify concerns on human health and nutrition. There are no concerns regarding the use of feedingstuffs 
from defatted soybean meal MON 87705 × MON 89788. The EFSA GMO Panel is of the opinion that soybean 
MON 87705 × MON 89788 is as safe, and at least as nutritious, as its comparator and commercial soybean 
varieties. There is no reason to expect interactions between the single events that could impact on the food and 
feed safety and the nutritional properties of soybean MON 87705 × MON 89788. There are no indications of an 
increased likelihood of establishment and spread of feral soybean plants. Potential interactions with the biotic 
and abiotic environment were not considered to be a relevant issue. The unlikely but theoretically possible 
transfer of the recombinant genes from soybean MON 87705 × MON 89788 to environmental bacteria does not 
give rise to any safety concern. The post-market environmental monitoring plan and reporting intervals are in 
line with the scope of the application. The EFSA GMO Panel considers that the information available for 
soybean MON 87705 × MON 89788 addresses the scientific comments raised by Member States. The EFSA 
GMO Panel concludes, considering the scope of the application, that soybean MON 87705 × MON 89788 is as 
safe as its comparator and non-GM soybean reference varieties with respect to potential effects on human and 
animal health and the environment. The GMO Panel recommends a post-market monitoring plan, focusing on 
import data and, if needed, on consumption data for the European population, for the marketed foods and feed. 
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SUMMARY 
Following the submission of application EFSA-GMO-NL-2011-100 under Regulation (EC) 
No 1829/2003 from Monsanto, the Panel on Genetically Modified Organisms of the European Food 
Safety Authority (EFSA GMO Panel) was asked to deliver a scientific opinion on the safety of 
herbicide-tolerant, increased oleic acid genetically modified (GM) soybean 
MON 87705 × MON 89788 (Unique Identifier MON-877Ø5-6 × MON-89788-1). The scope of 
application EFSA-GMO-NL-2011-100 is for food and feed uses, import and processing, but excludes 
cultivation within the European Union (EU). 
The soybean single events MON 87705 (expressing CP4 EPSPS and having an altered fatty acid 
profile) and MON 89788 (expressing CP4 EPSPS) were assessed previously and no concerns were 
identified. No safety issue was identified by updated bioinformatic analyses, nor reported by the 
applicant concerning the two single soybean events, since the publication of the respective scientific 
opinions. Consequently, the EFSA GMO Panel considers that its previous conclusions on the safety of 
the single soybean events remain valid. 
The two-event stack soybean MON 87705 × MON 89788 was produced by conventional crossing to 
produce soybean tolerant to glyphosate-based herbicides and having an altered fatty acid profile. The 
EFSA GMO Panel evaluated soybean MON 87705 × MON 89788 with reference to the scope and 
appropriate principles described in its guidelines for the risk assessment of GM plants and derived 
food and feed, the environmental risk assessment of GM plants and the post-market environmental 
monitoring of GM plants. The scientific evaluation of the risk assessment included molecular 
characterisation of the inserted DNA and analysis of the expression of the CP4 EPSPS protein. An 
evaluation of the comparative analyses of the compositional, agronomic and phenotypic characteristics 
was undertaken, and the safety of the newly expressed protein and the whole food/feed was evaluated 
with respect to potential toxicity, allergenicity and nutritional wholesomeness. An evaluation of 
environmental impacts and the post-market environmental monitoring plan was also undertaken. In 
accordance with the EFSA GMO Panel guidance document applicable to this application “For GM 
plants containing a combination of transformation events (stacked events) the primary concern for 
risk assessment is to establish that the combination of events is stable and that no interactions between 
the stacked events, that may raise safety concerns compared to the single events, occur. The risk 
assessment of GM plants containing stacked events focuses on issues related to: a) stability of the 
inserts, b) expression of the introduced genes and their products and c) potential synergistic or 
antagonistic effects resulting from the combination of the events”. 
The molecular data establish that the transformation events stacked in soybean 
MON 87705 × MON 89788 have the same molecular properties and characteristics as the single 
transformation events. The presence or absence of interactions that manifest at protein expression level 
could not be established by comparing the protein levels in the single events and the two-event stack. 
From the molecular characterisation, no indications of interactions between the events based on the 
biological functions of the newly expressed proteins were identified. 
The EFSA GMO Panel considered the compositional, phenotypic and agronomic data supplied and the 
observed statistically significant differences between soybean MON 87705 × MON 89788 and its 
comparator, in the light of the field trial design, measured biological variation and the level of the 
studied compounds in commercial non-GM soybean reference varieties. No differences in composition 
requiring further assessment for food/feed safety were observed between soybean 
MON 87705 × MON 89788 and its comparator, except for the intended trait i.e. altered fatty acid 
profile (reduced SFAs palmitic acid (C16:0) and stearic acid (C18:0), reduced PUFA linoleic acid 
(C18:2), and increased MUFA oleic acid (C18:1)).  
Nutritional assessment on soybean MON 87705 × MON 89788 oil and oil-containing food products 
did not identify concerns on human health and nutrition. There are no concerns regarding the use of 
feedingstuffs derived from defatted soybean meal MON 87705 × MON 89788. The EFSA GMO Panel 
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is of the opinion that soybean MON 87705 × MON 89788 is as safe, and at least as nutritious, as its 
comparator and commercial soybean varieties, in the context of its scope. 
Considering the intended modified soybean MON 87705 × MON 89788 nutritional composition, a 
proposal for a post market monitoring (PMM) plan needs to be provided by the applicant. EFSA 
recommends that the post-market monitoring plan should initially focus on the collection of import 
data for Europe; in the event of significant import, requiring a new exposure assessment, consumption 
data for the European population and concentration data for fatty acids in the oils would be needed. 
Considering the scope of application EFSA-GMO-NL-2011-100, there is no requirement for scientific 
information on possible environmental effects associated with the cultivation of soybean 
MON 87705 × MON 89788 in Europe. There are no indications of an increased likelihood of 
establishment and spread of feral soybean MON 87705 × MON 89788 plants in case of accidental 
release into the environment of viable GM soybean seeds. Potential interactions of soybean 
MON 87705 × MON 89788 with the biotic and abiotic environment were not considered to be a 
relevant issue by the EFSA GMO Panel. The unlikely but theoretically possible transfer of the 
recombinant genes from soybean MON 87705 × MON 89788 to environmental bacteria does not give 
rise to safety concerns owing to the lack of a selective advantage in the context of its intended uses. 
The post-market environmental monitoring plan provided by the applicant and the reporting intervals 
are in line with the scope of application EFSA-GMO-NL-2011-100. 
In delivering its scientific opinion, the EFSA GMO Panel took into account application EFSA-GMO-
NL-2011-100, additional information provided by the applicant, scientific comments submitted by the 
Member States and relevant scientific publications.  
In conclusion, the EFSA GMO Panel considers that the information available for soybean 
MON 87705 × MON 89788 addresses the scientific issues indicated by the Guidance document of the 
EFSA GMO Panel and the scientific comments raised by the Member States, and that soybean 
MON 87705 × MON 89788 is as safe as its comparator and is unlikely to have adverse effects on 
human and animal health and the environment in the context of its intended uses as proposed by the 
applicant. 
Considering the modified composition and nutritional values of soybean MON 87705 × MON 89788, 
the EFSA GMO Panel considered a specific labelling proposal provided by the applicant in 
accordance with Articles 13(2)(a) and 25(2)(c) of Regulation (EC) No 1829/2003. The applicant 
proposed that food and feed products within the scope of application should be labelled as “genetically 
modified soybean containing increased oleic acid oil”. The GMO Panel is of the opinion that the 
compositional data show that the fatty acid composition of seeds of soybean MON 87705 × MON 
89788 and derived oil has indeed been changed in relation to the comparator.
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BACKGROUND 
On 17 August 2011, the European Food Safety Authority (EFSA) received from the Competent 
Authority of The Netherlands application EFSA-GMO-NL-2011-100, for authorisation of genetically 
modified (GM) soybean MON 87705 × MON 89788 submitted by Monsanto within the framework of 
Regulation (EC) No 1829/2003 for food and feed uses, import and processing.
4
 
After receiving the application EFSA-GMO-NL-2011-100 and in accordance with Articles 5(2)(b) and 
17(2)(b) of Regulation (EC) No 1829/2003, EFSA informed Member States and the European 
Commission, and made the summary of the application available to the public on the EFSA website.
5
 
EFSA initiated a formal review of the application to check compliance with the requirements laid 
down in Articles 5(3) and 17(3) of Regulation (EC) No 1829/2003. On 1 June 2012 and 9 July 2012, 
EFSA received additional information (requested on 27 September 2011 and 22 June 2012). On 
30 July 2012, EFSA declared the application valid in accordance with Articles 6(1) and 18(1) of 
Regulation (EC) No 1829/2003. 
EFSA made the valid application available to Member States and the European Commission, and 
consulted nominated risk assessment bodies of Member States, including national Competent 
Authorities within the meaning of Directive 2001/18/EC
6
 following the requirements of Articles 6(4) 
and 18(4) of Regulation (EC) No 1829/2003 to request their scientific opinion. Member States had 
three months after the date of receipt of the valid application (from 26 October 2012 to 26 January 
2013)
7
 to make their opinion known. 
The EFSA GMO Panel carried out an evaluation of the scientific risk assessment of soybean 
MON 87705 × MON 89788 for food and feed uses, import and processing in accordance with Articles 
6(6) and 18(6) of Regulation (EC) No 1829/2003. The EFSA GMO Panel took into account the 
appropriate principles described in its guidelines for the risk assessment of GM plants and derived 
food and feed (EFSA GMO Panel, 2011a), the environmental risk assessment of GM plants (EFSA 
GMO Panel, 2010c) and on the post-market environmental monitoring of GM plants (EFSA GMO 
Panel, 2011b). Furthermore, the EFSA GMO Panel also took into consideration the scientific 
comments of Member States, the additional information provided by the applicant and the relevant 
scientific publications. 
The EFSA GMO Panel requested additional information from the applicant on 11 February 2013, 
10 April 2013, 11 April 2013, 27 June 2013, 5 September 2013, 29 November 2013, 
19 February 2014, 25 July 2014, 27 November 2014 and 27 February 2015. The applicant provided 
the requested information on 22 February 2013, 22 May 2013, 2 July 2013, 7 August 2013, 
18 September 2013, 17 February 2014, 12 May 2014, 24 October 2014, 9 April 2015 and 1 June 2015. 
In giving its scientific opinion to the European Commission, the Member States and the applicant, and 
in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003 (EC, 2003), EFSA has 
endeavoured to respect a time limit of six months from the acknowledgement of the valid application. 
As additional information was requested by the EFSA GMO Panel, the time limit of six months was 
extended accordingly, in line with Articles 6(1), 6(2), 18(1), and 18(2) of Regulation (EC) 
No 1829/2003. 
                                                     
4  Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically 
modified food and feed. OJ L 268, 18.10.2003, p. 1–23. 
5  Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2011-00954   
6  Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the 
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. OJ L 106, 12.3.2001, p. 1–38. 
7  Upon validation, application EFSA-GMO-NL-2011-100 was stopped pending the finalisation of application EFSA-GMO-
NL-2010-78 (soybean MON 88705). The scientific opinion on application EFSA-GMO-NL-2010-78 was adopted on 
28/9/2012. 
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According to Regulation (EC) No 1829/2003 (EC, 2003), this scientific opinion is to be seen as the 
report requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA 
overall opinion in accordance with Articles 6(5) and 18(5). 
TERMS OF REFERENCE 
The EFSA GMO Panel was requested to carry out a scientific assessment of soybean 
MON 87705 × MON 89788 for food and feed uses, import and processing in accordance with Articles 
6(6) and 18(6) of Regulation (EC) No 1829/2003. 
Where applicable, any conditions or restrictions which should be imposed on the placing on the 
market and/or specific conditions or restrictions for use and handling, including post-market 
monitoring requirements based on the outcome of the risk assessment and, in the case of GMOs or 
food/feed containing or consisting of GMOs, conditions for the protection of particular 
ecosystems/environment and/or geographical areas should be indicated in accordance with Articles 
6(5)(e) and 18(5)(e) of Regulation (EC) No 1829/2003. 
The EFSA GMO Panel was not requested to give an opinion on information required under Annex II 
to the Cartagena Protocol. The EFSA GMO Panel did consider if there is a need for specific labelling 
in accordance with Articles 13(2) (a) and 25(2)(c) of Regulation (EC) No 1829/2003. However, it did 
not consider proposals for methods of detection (including sampling and the identification of the 
specific transformation event in the food/feed and/or food/feed produced from it), which are matters 
related to risk management.  
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ASSESSMENT 
1. Introduction 
Application EFSA-GMO-NL-2011-100 covers the two-event stack soybean 
MON 87705 × MON 89788 produced by conventional crossing of events MON 87705 and MON 
89788. The scope of this application is for food and feed uses, import and processing, but excludes 
cultivation within the European Union (EU). 
European Food Safety Authority (EFSA) guidance establishes the principle that “For GM plants 
containing a combination of transformation events (stacked events) the primary concern for risk 
assessment is to establish that the combination of events is stable and that no interactions between the 
stacked events, that may raise safety concerns compared to the single events, occur. The risk 
assessment of GM plants containing stacked events focuses on issues related to: a) stability of the 
inserts, b) expression of the introduced genes and their products and c) potential synergistic or 
antagonistic effects resulting from the combination of the events” (EFSA GMO Panel, 2011a). 
Soybean MON 87705 × MON 89788 was developed to confer tolerance to glyphosate  
(N-(phosphonomethyl)glycine)-based herbicides and to have an altered fatty acid profile (increased 
oleic acid). Tolerance to glyphosate is achieved by expression of the CP4 5-enolpyruvylshikimate-3-
phosphate synthase (CP4 EPSPS). The increased oleic acid phenotype is achieved by introducing 
fragments of the soybean FAD2-1A and FATB1-A genes, under the control of a promoter 
predominantly active in seeds. The genetic modification results in an inhibition of the expression of 
the FAD2-1A and FATB1-A genes by RNA interference (RNAi), resulting in reduced levels of the 
corresponding fatty acid Δ12-desaturase and palmitoyl acyl carrier protein thioesterase enzymes. The 
transport of the saturated fatty acid (SFA) out of the plasmid is thus decreased, the conversion of oleic 
acid to linoleic acid is inhibited (linoleic acid decreases), and the oleic acid level increases. 
The two single soybean events MON 87705 and MON 89788 have been previously assessed (see 
Table 1) on the basis of experimental data. No concerns for human or animal health or environmental 
safety were identified. 
Table 1:  Single soybean events already assessed by the EFSA GMO Panel 
Events Application or mandate EFSA Scientific Opinions 
MON 87705 EFSA-GMO-NL-2010-78 EFSA GMO Panel (2012) 
MON 89788 EFSA-GMO-NL-2006-36 EFSA (2008) 
2. Issues raised by Member States 
Issues raised by Member States on soybean MON 87705 × MON 89788 were considered in this 
scientific opinion and are addressed in detail in Annex G of the EFSA overall opinion.
8
 
3. Updated information on single events 
Since the publication of the scientific opinions on the single soybean events by the EFSA GMO Panel 
(EFSA, 2008; EFSA GMO Panel, 2012), no safety issues pertaining to the two single events have been 
reported by the applicant. 
Updated bioinformatic analyses
9
 on the junction sites between the genomic DNA and inserts present in 
the events MON 87705 and MON 89788 confirmed that no known endogenous genes were disrupted 
by any of the inserts. Updated bioinformatic analyses
10
 of the amino acid sequence of the newly 
                                                     
8 http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2011-00954 
9 Additional information: 03/03/2015. 
10 Additional information: 03/03/2015. 
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expressed protein CP4 EPSPS and other Open Reading Frames present within the insert and spanning 
the junction sites revealed no significant similarities to known toxins or allergens.  
In order to conclude on the possibility of horizontal gene transfer (HGT) by homologous 
recombination (HR), sequence identity analyses of the regions of bacterial origin of MON 87705 and 
MON 87705 were performed. In soybean MON 87705, a pair of identical sequences of sufficient 
length (259bp and 275bp) were identified. However, the similarity in the bacterial genome is with a 
single sequence, and the length of the sequence that could be transferred is more than 10kb. Therefore, 
double HR is unlikely. In soybean MON 89788, no pairs of sequences with a sufficient length of 
identity and the correct orientation with bacterial genomes were found to facilitate the transfer of 
insert sequences to bacterial recipients by double HR. The likelihood and potential consequences of 
the plant-to-bacteria gene transfer are described in Section 4.4.2.2. 
Having assessed the updated information on soybean MON 87705 and MON 89788, the EFSA GMO 
Panel considers that its previous conclusions on the safety of the single soybean events remain valid. 
4. Risk assessment of the two-event stack MON 87705 × MON 89788 
4.1. Molecular characterisation 
Possible interactions between the known biological functions conferred by the individual inserts and 
interactions that would manifest at protein expression level are considered. 
4.1.1. Genetic elements and their biological functions 
Soybean MON 87705 and MON 89788 are combined by conventional crossing to generate soybean 
MON 87705 × MON 89788. The structure of the inserts present in soybean 
MON 87705 × MON 89788 are described in detail in the EFSA GMO Panel scientific opinions 
(EFSA, 2008; EFSA GMO Panel, 2012), and no new genetic modifications were involved. Genetic 
elements in the expression cassettes of the single events are summarised in Table 2. 
Table 2:  Genetic elements in the expression cassettes of the events stacked in soybean 
MON 87705 × MON 89788. 
Event Promoter 5 UTR Transit peptide Coding region Terminator 
MON 
87705  
7Sα’ from the Sphas1 
gene (Glycine max) 
 
 
 
 
Enhancer of 35S RNA 
promoter of FMV 
(Figwort Mosaic 
Virus)/Tsf1 promoter 
(Arabidopsis thaliana) 
 
7Sα’ from the 
Sphas1 gene 
(G. max) 
 
 
 
5 UTR and 
intron from 
Tsf1 (A. 
thaliana) 
no 
 
 
 
 
 
CTP2 from 
ShkG encoding 
EPSPS (A. 
thaliana) 
 
FAD2-1A (partial 
intron), FATB1-A 
(partial 5’UTR 
and CTP) 
(G. max) 
 
CP4 epsps 
(Agrobacterium 
tumefaciens sp. 
strain CP4) 
H6 (Gossypium 
barbadense) 
 
 
 
 
E9 (Rbc2) 
(Pisum sativum) 
MON 
89788 
35S promoter from 
FMV and promoter 
from Tsf1 gene 
(A. thaliana) 
5 UTR and 
intron from 
Tsf1 gene 
(A. thaliana) 
ShkG 
(A. thaliana) 
CP4 epsps 
(A. tumefaciens 
strain CP4) 
3 UTR of RbcS2 
(P. sativum) 
CTP, chloroplast transit peptide 
UTR, untranslated region. 
Biological functions conferred by the inserts in soybean MON 87705 × MON 89788 are summarised 
in Table 3. CP4 EPSPS is already present together with the FAD2-1A/FATB1-A suppression cassette 
in event MON 87705. The addition of another copy of the CP4 EPSPS–coding gene from event 
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MON 89788 can be expected to increase the total amount of CP4 EPSPS, the ratio of CP4 EPSPS to 
endogenous EPSPS, and the herbicide tolerance of the stacked event. 
Table 3:  Biological functions of the events stacked in soybean MON 87705 × MON 89788. 
Event Protein Function in donor organism Function in GM plant 
MON 87705 
CP4 EPSPS  
 
 
 
 
 
 
 
 
FAD2-1A/ 
FATB1-A 
Donor organism: Agrobacterium 
sp. strain CP4 
EPSPS) synthase is an enzyme 
involved in the shikimic acid 
pathway for aromatic amino acid 
biosynthesis in plants and 
microorganisms (Herrmann, 
1995) 
 
Donor organism: Glycine max 
FAD2-1A ∆-12 desaturase; 
FATB1-A palmitoyl acyl carrier 
protein thioesterase. Both 
proteins function in fatty acid 
biosynthesis 
The bacterial CP4 EPSPS protein 
confers tolerance to glyphosate-
based herbicides as it has a much 
lower affinity towards glyphosate 
than the plant endogenous 
enzyme  
 
 
 
The sense and antisense segments 
of FAD2-1A and FATB1-A 
express RNA that contains an 
inverted repeat of the gene 
segments. This transcript 
produces double-stranded RNA 
that via RNAi leads to the 
degradation of endogenous 
FAD2-1A and FATB1-A 
mRNAs. As a consequence, the 
oil is higher in oleic acid and 
lower in saturated and 
polyunsaturated fatty acids 
MON 89788 CP4 EPSPS Same as above Same as above 
4.1.2. Integrity of the events in soybean MON 87705 × MON 8978811 
The genetic stability of the inserted DNA over multiple generations in the single soybean events 
MON 87705 and MON 89788 was demonstrated previously (EFSA, 2008; EFSA GMO Panel, 2012). 
Integrity of the events in soybean MON 87705 × MON 89788 was demonstrated by Southern 
analyses. 
4.1.3. Information on the expression of the inserts12 
The levels of the newly expressed CP4 EPSPS protein in soybean MON 87705 × MON 89788 were 
analysed by enzyme-linked immunosorbent assays (ELISAs). Tissue samples were collected from 
eight field trial sites in the USA during 2009. The trial included appropriate comparators. Protein 
levels were determined in forage, seeds, leaves and roots. Data on seed are reported and discussed 
below (Table 4). The CP4 EPSPS protein levels in the two-event stack were slightly higher than the 
corresponding levels in the single-event soybean plants.  
Table 4:  Levels of CP4 EPSPS protein (μg/g dry weight) in seed from soybean 
MON 87705 × MON 89788 and from single soybean events MON 87705 and MON 89788. 
 MON 87705 × MON 89788 MON 87705 MON 89788 
Mean ± SD  
Range  
270 ± 34 
210-340 
240 ± 35 
190-310 
170 ± 28 
98-220 
                                                     
11 Dossier: Part II—Section A2.2.2. 
12 Dossier: Part II—Section A2.2.3. 
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4.1.4. Conclusion 
The molecular data establish that the transformation events stacked in soybean 
MON 87705 × MON 89788 have the same molecular properties and characteristics as the single 
transformation events. The presence or absence of interactions that manifest at protein expression level 
could not be established by comparing the protein levels in the single events and the two-event stack. 
The molecular characterisation revealed no indications of interactions between the events based on the 
biological functions of the newly expressed proteins. 
4.2. Comparative analysis 
4.2.1. Evaluation of relevant scientific data 
4.2.1.1. Choice of comparator and production of material for the comparative analysis13 
Field trials for the comparative analysis of agronomic and phenotypic characteristics and 
compositional data of MON 87705 × MON 89788 were performed in the USA in 2009. In these field 
trials, soybean MON 87705 × MON 89788 (both untreated and treated with the target herbicide 
glyphosate) was compared with the control soybean material A3525, which has a genetic background 
similar to soybean MON 87705 × MON 89788.
14
 The Asgrow variety A3525 was the commercial 
soybean variety used to establish the transformation event MON 87705, and is a progeny (crossed with 
the A3469 variety) of the soybean variety A3244 used to establish the transformation event 
MON 89788.  
The field trials were performed at nine separate sites within the soybean cultivation areas of the USA. 
Eight of the nine sites were used for the agronomic and phenotypic comparison,
15
 and eight were used 
for comparative compositional studies of soybean seed and forage.
16
 Seven of the nine field trials were 
used for both compositional and agronomic/phenotypic analysis. At each field trial site, the soybean 
materials were planted in a randomised complete block design with four replicates per block. The 
plant materials grown at each site were soybean MON 87705 × MON 89788, the comparator (non-GM 
soybean A3525) and three different commercial non-GM soybean reference varieties,
17
 all treated 
using typical agricultural practices, as well as soybean MON 87705 × MON 89788 additionally treated 
with glyphosate-based herbicides. 
4.2.1.2. Statistical analysis of field trials data 
The statistical analysis of the agronomic, phenotypic and compositional data followed the 
recommendations by the EFSA GMO Panel (EFSA, 2010a, 2011a). This includes a test of difference 
to determine whether or not the GM plant is different from its comparator, and a test of equivalence to 
determine whether or not the GM plant falls within the range of natural variation estimated from the 
non-GM soybean reference varieties. As described in EFSA GMO Panel (2011a), the result of the 
equivalence test is categorised into four possible outcomes to facilitate drawing conclusions with 
respect to the presence or absence of equivalence. These four categories are category I, indicating full 
                                                     
13 Dossier: Part II—Sections A.3.1–3.2; additional information: 18/9/2013, 17/2/2014 and 12/5/2014. 
14  Using single nucleotide polymorphism (SNP) marker technology, soybean MON 87705 × MON 89788 was shown to be 
approximately 90% similar to the A3525 genetic background. 
15  A field trial site in Indiana (INRC) was dropped from the agronomic/phenotypic due to sample mishandling during the 
vegetative stage. As the mishandling did not impact on the resulting forage and grain samples harvested, compositional 
data on this material was included in the analysis.  
16  A field trial site in Illinois (ILWY) was dropped from the compositional studies due to contamination of three of the four 
control samples with unintended traits. As this contamination had not influenced the agronomic/phenotypic measurements, 
the data collected from this field trial site were included in the agronomic/phenotypic analysis. 
17  Altogether, 18 commercial non-GM varieties were used for the compositional analysis: Pioneer 93B15, Schillinger 
TP31834, Wilken 3316, FS 3591, Hoshea, Garst 3585N, Williams 82, Pioneer 93M52, Croplan HT3596STS, Hoegemeyer 
333, Midland 363, Quality Plus 365C, Schillinger 388.TC, Maverick, Lewis 372, Crows C37003N, NK S38-T8, and NK 
32Z3. For the assessment of phenotypic/agronomic characteristics, 19 varieties were used: 16 were in common with the 
compositional analysis (all except Hoegemeyer 333 and Midland 363), and in addition Stewart SB3454, Channel Bio 3461 
and Schillinger 348.TC were used. 
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equivalence; category II, indicating that equivalence is more likely than non-equivalence; category III, 
indicating that non-equivalence is more likely than equivalence; and category IV, indicating non-
equivalence. 
4.2.1.3. Agronomic and phenotypic characteristics18 
The phenotypic and agronomic characteristics evaluated were early stand count, plant vigour, days to 
50 % flowering, plant height, lodging, pod shattering
19
, final stand count, seed moisture content, 100-
seed weight and yield. Growth stage data were also collected but were not analysed statistically. 
In the analysis of soybean MON 87705 × MON 89788 not treated with glyphosate, the test of 
difference of phenotypic and agronomic characteristics identified statistically significant differences 
between soybean MON 87705 × MON 89788 and the comparator for six endpoints. The test of 
equivalence showed that four of these endpoints (plant height, final stand count, 100 seed weight, and 
yield) fell into equivalence category I and two (early stand count and plant vigour) fell into 
equivalence category II. In all cases plant vigour ratings were in the range excellent to normal for 
soybean. 
In the analysis of soybean MON 87705 × MON 89788 treated with glyphosate, the test of difference 
identified statistically significant differences between soybean MON 87705 × MON 89788 and its 
comparator for seven endpoints. The equivalence test showed that five of these endpoints (days to 
50% flowering, plant height, final stand count, 100 seed weight, and yield) fell into equivalence 
category I and two (early stand count and plant vigour) fell into equivalence category II. Also for 
glyphosate-treated soybean MON 87705 × MON 89788, plant vigour ratings were in the range of 
excellent to normal for soybean. 
As for early stand count and plant vigour, full equivalence with the range of non-GM reference 
varieties could not be demonstrated (for either of the two spraying regimens). Because these endpoints 
are relevant for the assessment of possible changes in persistence and invasiveness of the GM 
soybean, the significant differences observed in early stand count and plant vigour are further assessed 
for their potential environmental impact in Section 4.4. 
The plots used for the ecological studies were those that had not been sprayed with glyphosate. Plant 
response (damage) to three abiotic stressors, three diseases and three arthropod pests was evaluated 
four times during the growing season at each field trial site. No differences between soybean 
MON 87705 × MON 89788 and the comparator were noted in any of the comparisons. These data 
indicated no difference in environmental interactions between soybean MON 87705 × MON 89788 
and the comparator A3525. 
  
                                                     
18  Dossier: Part II— Section A3.4; additional information: 18/9/2013 and 17/2/2014. 
19 Pod shattering could not be statistically analysed in the equivalence test because of the variance among the commercial 
non-GM reference soybean varieties was too small. However, no significant differences were identified between soybean 
MON 87705  MON 89788 and the comparator. 
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4.2.1.4. Compositional analysis20 
Soybean forage and seeds harvested from the field trials were analysed for 67 constituents (60 in 
seeds
21
 and 7 in forage
22
), including the key constituents recommended by the Organisation for 
Economic Co-operation and Development (OECD, 2001). Eighteen rarely occurring fatty acids in 
soybean with more than 50 % of the observations below the limit of quantification were excluded from 
the statistical analysis,
23
 the analysis therefore included 49 compounds (42 in seed and 7 in forage). 
The compositional endpoints that are further discussed based on the results of statistical analysis are 
presented in Table 5.  
As expected, statistically significant differences of considerable magnitude between soybean 
MON 87705 × MON 89788 (both sprayed and not sprayed with the target herbicide) and the 
comparator were found for several fatty acids, demonstrating the intended effect of event MON 87705. 
The results for the fatty acid profile composition in seeds of soybean MON 87705 × MON 89788 
(Table 5) are therefore discussed separately from those for the other endpoints. 
The data in Table 5 confirm the expected decrease in the relative level (% total fatty acid (FA)) of 
palmitic acid (16:0) (about 80 % relative decrease for both treatments) and stearic acid (18:0) (about 
25 %), and the increased level of oleic acid (18:1) (about 240 %) accompanied by a decrease in 
linoleic acid (18:2) (about 65%); the level of eicosenoic acid (20:1) was also increased (by about 
80 %). Less marked changes were detected for the other fatty acids: a decrease in -linolenic acid 
(18:3) (about 6 %) and behenic acid (22:0) (about 7 %), and an increase in arachidic acid (20:0) (about 
17 %). The relative level of all the fatty acids fell outside the equivalence limits established from the 
non-GM soybean reference varieties (equivalence category IV), with the exception of -linolenic acid 
(18:3) which was found equivalent for both treatments (equivalence category I), and arachidic acid 
(20:1) which fell into equivalence category III for soybean MON 87705 × MON 89788 sprayed with 
the target herbicide. For all the eight fatty acids, a significant genotype × environment interaction was 
identified: this result is associated with the high between-site variability of the fatty acid content of 
soybean MON 87705 × MON 89788 (e.g. mean linoleic acid content per site ranges approximately 
from 12 % FA to 28 % FA). The nutritional consequences of this variation are assessed in 
Section 4.3.4. 
With regard to non-fatty acid compounds, the test of difference between soybean 
MON 87705 × MON 89788 (not sprayed with the intended herbicide) and the comparator identified 
statistically significant differences for 17 endpoints, one in forage (carbohydrate level) and 16 in 
seeds.
24
 The equivalence test showed that 14 of these endpoints fell into equivalence category I or II 
and two (arginine and cystine levels) under equivalence category III (Table 5); carbohydrate level in 
forage fell into equivalence category I. Given the well-known function of arginine and cystine, the 
differences observed between soybean MON 87705 × MON 89788 and the comparator were 
                                                     
20  Dossier: Part II— Section A3.3; additional information: 18/9/2013 and 17/2/2014. 
21 Proximates (protein, fat, ash and moisture), carbohydrates by calculation, fibre fractions (acid detergent fibre (ADF) and 
neutral detergent fibre (NDF)), amino acids (alanine, arginine, aspartic acid, cystine, glutamic acid, glycine, histidine, 
isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine), fatty acids 
(caprylic acid (C8:0), capric acid (C10:0), lauric acid (C12:0), myristic acid (C14:0), myristoleic acid (C14:1), 
pentadecylic acid (C15:0), pentadecenoic acid (C15:1), palmitic acid (C16:0), palmitoleic acid (C16:1), heptadecanoic acid 
(C17:0), heptadecenoic acid (C17:1), stearic acid (C18:0), oleic acid (C18:1), octadecenoic acid (C18:1), linoleic acid 
(C18:2), (9c,15c) isomer of linoleic acid (C18:2), (6c,9c) isomer of linoleic acid (C18:2), linolenic acid (C18:3), γ-linolenic 
acid (C18:3), arachidic acid (C20:0), eicosenoic acid (C20:1), eicosadienoic acid (C20:2), eicosatrienoic acid (C20:3), 
arachidonic acid (C20:4), behenic acid (C22:0), and lignoceric acid (C24:0)), the micronutrient vitamin E, anti-nutrients 
(phytic acid, trypsin inhibitor, lectin, stachyose and raffinose) and other secondary metabolites (isoflavones: daidzein, 
genistein, and glycitein). 
22 Proximates, carbohydrates by calculation and fibre fractions (ADF, NDF). 
23  Caprylic acid (C8:0), capric acid (C10:0), lauric acid (C12:0), myristic acid (C14:0), myristoleic acid (C14:1), pentadecylic 
acid (C15:0), pentadecenoic acid (C15:1), palmitoleic acid (C16:1), heptadecanoic acid (C17:0), heptadecenoic acid 
(C17:1), octadecenoic acid (C18:1), (9c,15c) isomer of linoleic acid (C18:2), (6c,9c) isomer of linoleic acid (C18:2), γ-
linolenic acid (C18:3), eicosadienoic acid (C20:2), eicosatrienoic acid (C20:3), arachidonic acid (C20:4), lignoceric acid 
(C24:0). 
24  Levels of carbohydrates, protein, arginine, aspartic acid, cystine, glutamic acid, glycine, histidine, leucine, lysine, serine, 
vitamin E, phytic acid, raffinose, trypsin inhibitor and genistein. 
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considered to be of no relevance for food and feed safety. For arginine, a significant genotype × 
environment interaction was identified, but the magnitude of individual-site differences between the 
GM soybean and the comparator was considered of no relevance for food and feed safety. 
In the corresponding statistical analysis for soybean MON 87705 × MON 89788 treated with 
glyphosate compared with the comparator A3525, 11 significant differences (apart from the eight fatty 
acids) were found for seed constituents,
25
 and none for forage constituents. The equivalence test 
showed that nine of the significantly different endpoints fell into equivalence category I or II, and 
cystine and methionine levels fell into equivalence category III (Table 5). Given the well-known 
function of cystine and methionine, the differences observed between glyphosate-treated soybean 
MON 87705 × MON 89788 and the comparator were considered to be of no relevance for food and 
feed safety. 
Table 5:  Compositional endpoints that are further discussed based on the results of the statistical 
analysis: means (for the comparator and the GM soybean) and equivalence limits (from the non-GM 
reference varieties) estimated from field trials data collected in 2009. For the GM soybean, 
significantly different entries are marked with an asterisk, while the outcomes of the test of 
equivalence are differentiated by greyscale backgrounds: white (equivalence category I or II), light 
grey (equivalence category III) and dark grey (equivalence category IV). 
Endpoint Comparator 
(A3525) 
Soybean MON 87705  MON 89788 Equivalence limits 
from non-GM 
reference varieties  
Untreated 
(a)
 Treated 
(b)
 
Fatty acids 
Palmitic acid (16:0) 
(% FA) 
(c)
 
11.53 2.49* 2.50* (9.54, 11.71) 
Stearic acid (18:0) 
(% FA) 
(c)
 
3.84 2.85* 2.90* (3.29, 4.31) 
Oleic acid (18:1) 
(% FA) 
(c)
 
19.15 64.81* 65.04* (15.05, 25.17) 
Linoleic acid (18:2) 
(% FA) 
(c)
 
54.74 19.63* 19.4* (50.65, 59.52) 
Linolenic acid (18:3) 
(% FA) 
(c)
 
10.01 9.45* 9.38* (8.68, 10.52) 
Arachidic acid (20:0) 
(% FA) 
(c)
 
0.29 0.24* 0.24* (0.25, 0.34) 
Eicosenoic acid (20:1) 
(% FA) 
(c)
 
0.15 0.27* 0.27* (0.13, 0.19) 
Behenic acid (22:0) 
(% FA) 
(c)
 
0.29 0.27* 0.27* (0.29, 0.35) 
Amino acids 
Arginine (% dw) 3.06 3.16* 3.12* (2.72, 3.15) 
Cystine (% dw) 0.62 0.64* 0.64* (0.57, 0.64) 
Methionine (% dw) 0.58 0.59 0.59* (0.54, 0.59) 
(a): Untreated: soybean MON 87705 × MON 89788 not sprayed with the target herbicide (glyphosate). 
(b): Treated: soybean MON 87705 × MON 89788 sprayed with the target herbicide (glyphosate). 
(c): Fatty acid proportions are given as percentages of total fatty acids.  
dw, dry weight. 
 
The EFSA GMO Panel assessed all compositional differences between soybean 
MON 87705 × MON 89788 and the comparator, the measured biological variation in commercial non-
GM soybean varieties, and concluded that soybean MON 87705 × MON 89788 has an altered fatty 
acid composition as compared with soybean A3525, the modified soybean oil being characterised by a 
reduced proportion of palmitic acid (16:0) and stearic acid (18:0), and an increase in oleic acid (18:1) 
                                                     
25 Levels of ash, carbohydrates, arginine, cystine, histidine, lysine, methionine, tyrosine, vitamin E, phytic acid and genistein. 
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accompanied by a decrease in linoleic acid (18:2) (Table 5). With regard to non-fatty acid constituents, 
after considering the well-known biological role of the compounds concerned and the magnitudes of 
the changes observed (Table 5), the EFSA GMO Panel did not identify any need for further 
assessment with regard to food and feed safety. 
4.2.2. Conclusion 
The EFSA GMO Panel confirms that soybean MON 87705 × MON 89788 differs from the comparator 
and the non-GM soybean reference varieties by having an altered fatty acid profile. None of the other 
differences identified in the composition of grain and forage obtained from soybean 
MON 87705 × MON 89788 necessitated further assessment regarding food and feed safety. 
The differences in agronomic and phenotypic characteristics observed in early stand count and plant 
vigour between soybean MON 87705 × MON 89788 and the comparator are further assessed for their 
potential environmental impact in Section 4.4. 
4.3. Food and feed safety assessment 
4.3.1. Effect of processing26 
Soybean MON 87705 × MON 89788 will undergo the existing methods of production and processing 
used for commercial soybean. No novel methods of production and processing are envisaged.  
Seeds of soybean MON 87705 × MON 89788 collected from the 2009 USA field trials were processed 
into refined bleached deodorised (RBD) oil and analysed for fatty acid composition.
27
 The EFSA 
GMO Panel concluded that the intended effects of the genetic modification and the effects on the fatty 
acid pattern already seen in the analysis of unprocessed soybean seeds (Table 5) were also reflected in 
the composition of RBD oil obtained from soybean MON 87705 × MON 89788 (Table 6). 
Table 6:  Fatty acid composition of RBD oil and seed oil of soybean MON 87705 × MON 89788. 
Fatty acid RBD oil (% total FA) 
(a)
 Seed oil (% total FA) 
Palmitic acid (16:0) 2.46 2.50 
Stearic acid (18:0) 2.88 2.90 
Oleic acid (18:1) 63.6 65.04 
Linoleic acid (18:2) 20.8 19.40 
Linolenic acid (18:3) 9.42 9.38 
Arachidic acid (20:0) 0.23 0.24 
Eicosenoic acid (20:1) 0.30 0.27 
Behenic acid (22:0) 0.26 0.27 
(a): Average rounded value from duplicate fatty acid analyses of RBD oil. 
 
The influence of the altered fatty acid pattern seen in the unprocessed soybean seeds on the various 
products obtained after seed processing was described and assessed by the EFSA GMO Panel for 
soybean MON 87705 (EFSA GMO Panel, 2012). The products studied included RBD oil, isolated soy 
protein, toasted defatted meal and crude lecithin.  
As observed for MON 87705, the altered fatty acid composition of soybean 
MON 87705 × MON 89788 seeds is also reflected in the composition of the RBD oil. 
The oil of soybean MON 87705 × MON 89788 has a fatty acid profile that is more similar to other 
types of vegetable oil (e.g. olive oil) than conventional soybean. Therefore, the production of food 
                                                     
26 Dossier: Part II—Section A3.5.. 
27 Additional information: 3/6/2015. 
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quality oil from soybean MON 87705 × MON 89788 (as from MON 87705) is expected to be kept 
separated from production of oil from conventional soybean varieties. 
4.3.2. Toxicology 
4.3.2.1. Toxicological assessment of newly expressed proteins28 
The only newly expressed protein in soybean MON 87705 × MON 89788 is the CP4 EPSPS protein, 
expressed by both events. The EFSA GMO Panel has previously assessed this protein in the single 
events (see Table 1), as well as in other GMO applications (e.g. EFSA GMO Panel, 2014) and no 
safety concern for humans and animals was identified. The EFSA GMO Panel is not aware of any new 
information that would change these conclusions. The levels of CP4 EPSPS protein observed in seeds 
of soybean MON 87705 × MON 89788 are not considered to give rise to any concern regarding food 
and feed safety. 
4.3.2.2. Toxicological assessment of components other than newly expressed proteins 
The compositional analysis of soybean MON 87705 × MON 89788 identified changes in the fatty acid 
composition of the seeds (see Table 5).   
All of these fatty acids occur naturally in the diet of humans and animals; the safety impact of the 
altered fatty acid profile is evaluated in Section 4.3.4. 
4.3.3. Animal studies with the food/feed derived from GM plants 
A report of a 42-day feeding study with a total of 960 male and female chickens for fattening (one-
day-old Cobb 500) was provided.
29
 The birds were randomly allocated to eight dietary treatments with 
120 chickens per treatment (five pens/treatment per gender, initially 12 birds per pen, reduced to 10 on 
day seven). Soybean MON 87705 × MON 89788 (verified by PCR) was compared with its comparator 
and to six non-GM commercial varieties (Anand, Jake, Gateway 427, Hoffman HS387, NuPride 3202 
and NuTech 315). Soybean MON 87705 × MON 89788 was treated with glyphosate.
30
 The 
comparator and the commercial varieties were grown following local agriculture practice. The diets 
consisted mainly of corn and soybean meal (about 33 and 29 % in the starter and grower/finisher diets, 
respectively). Before feed formulation, all toasted defatted soybean meals were analysed for 
proximates, amino acids, mycotoxins and pesticide residues, corn and corn gluten meal for proximates 
and amino acids.
31
 Toasted defatted soybean meal of MON 87705 × MON 89788 contained residual 
oil (1 %)
32
 with the expected compositional changes in fatty acids profile. The starter diets (given on 
days 0-21) were calculated to contain 21.7 % crude protein (CP), 1.2 % lysine, 0.6 % methionine and 
3090 kcal ME/kg. The grower/finisher diets (given on days 21-42) were calculated to contain 20.0 % 
CP, 1.1 % lysine, 0.55 % methionine and 3 135 kcal ME/kg. The calculated data were confirmed by 
analysis. Feed and water were provided for ad libitum intake. 
Chickens were observed twice daily for clinical signs; deaths were recorded and necropsy performed 
on all birds found dead. Body weight and feed intake were measured at the start and at day 42. On day 
43 and day 44, males and females were processed for carcass evaluation (yield, dressing percentage, 
and weight of thighs, breast, wings, legs, abdominal fat and whole liver). Data were statistically 
analysed by a two-factor analysis of variance (ANOVA) (diet and sex), and pair-wise comparison was 
made by the Fischer’s Least Significant Difference test. A mixed linear model was applied to compare 
the soybean MON 87705 × MON 89788 group with the mean of all non-GM varieties.  
                                                     
28 Dossier: Part II—Section A4.2. 
29 Dossier: Part II—MSL0022972; additional information: 17/2/2014.  
30 Additional information: 17/2/2014. 
31 Additional information: 17/2/2014. 
32 Dossier: Part I—MSL0022972; additional information: 17/2/2014. 
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Mortality was low (< 2 % in any treatment group). No significant treatment  sex interaction was 
detected for performance characteristics. Overall, no significant difference was seen in final body 
weight (about 2.8 kg), feed intake (about 4.4 kg), or feed to gain ratio (about 1.61) between the 
soybean MON 87705 × MON 89788 and the comparator, or the soybean MON 87705 × MON 89788 
and the mean of the non-GM varieties. Carcass parameters were not significantly different between 
soybean MON 87705 × MON 89788 and the comparator or the overall mean of all non-GM varieties. 
There was no evidence of unintended effects introduced by the genetic modification at the inclusion 
levels of about 30 % soybean MON 87705 × MON 89788 in complete feed. The EFSA GMO Panel 
concluded that toasted defatted soybean meal from MON 87705 × MON 89788 is as nutritious as the 
comparator and six non-GM commercial varieties. 
4.3.4. Allergenicity 
For the allergenicity assessment, a weight-of-evidence approach is followed, taking into account all of 
the information obtained on the newly expressed proteins, since no single piece of information or 
experimental method yields sufficient evidence to predict allergenicity (EFSA GMO Panel, 2011a; 
Codex Alimentarius, 2009). In addition, when known functional aspects of the newly expressed 
protein or structural similarity to known adjuvants may indicate an adjuvant activity, the possible role 
of these proteins as adjuvants is considered (EFSA GMO Panel, 2011a). When newly expressed 
proteins with a potential adjuvant activity are expressed together, possible interactions increasing 
adjuvanticity and impacting on the allergenicity of the GM crop are assessed. 
4.3.4.1. Assessment of allergenicity of the newly expressed proteins33 
With regard to allergenicity, the EFSA GMO Panel has previously evaluated the safety of the CP4 
EPSPS protein, and no concerns about allergenicity were identified in the context of the applications 
assessed (e.g. EFSA, 2008; EFSA GMO Panel 2012, 2014). No new information on allergenicity of 
the newly expressed protein that might change the previous conclusions of the EFSA GMO Panel has 
become available. As regards adjuvanticity, no information available on the structure or function of 
the newly expressed CP4 EPSPS protein would suggest an adjuvant effect of the protein in soybean 
MON 87705 × MON 89788 resulting in or increasing an eventual immunoglobulin E (IgE) response to 
a bystander protein. 
 
The EFSA GMO Panel considers that there are no indications that the newly expressed CP4 EPSPS 
protein in soybean MON 87705  MON 89788 may be allergenic. 
4.3.4.2. Assessment of allergenicity of the whole GM plant34 
Soybean is considered to be a common allergenic food
35
 (OECD, 2012). Therefore, any potential 
change in the endogenous allergenicity of the GM plant when compared with that of its comparator(s) 
should be assessed (EFSA GMO Panel, 2011a). Such assessments were performed for the single 
events soybean MON 87705 and soybean MON 89788, and no reasons for concern were identified by 
the EFSA GMO Panel (EFSA 2008; EFSA GMO Panel. 2012). 
At the request of the EFSA GMO Panel, the applicant provided an assessment of the endogenous 
allergenicity
36
 by comparing protein extracts of soybean MON 87705 × MON 89788 and of its 
comparator as determined by gel electrophoresis followed by mass spectrometry. The intensities of the 
bands corresponding to specific allergens were analysed. No relevant differences in the allergen 
                                                     
33 Dossier: Part II—Section A5; additional information: 3/3/2015. 
34 Dossier: Part II—Section A5; additional information: 22/2/2013; 7/8/2013; 17/2/2014. 
35 Directive 2007/68/EC of the European Parliament and of the Council of 27 November 2007 amending Annex IIIa to 
Directive 2000/13/EC of the European Parliament and of the Council as regards certain food ingredients. OJ L 310, 
27.11.2007, p. 11–14. 
36 Additional information: 22/2/2013; 7/8/2013; 17/2/2014. 
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content between the protein extracts of soybean MON 87705 × MON 89788 and of its comparator 
were identified.  
The EFSA GMO Panel considers that there is no evidence that the genetic modification might 
significantly change the overall allergenicity of soybean MON 87705 × MON 89788 compared with 
that of its comparator. 
4.3.5. Nutritional assessment of GM food/feed 
4.3.5.1. Human nutritional assessment 
The main product for human consumption from soybean is the oil. The nutritional consequences of the 
modifications to the fatty acid profile were assessed in the context of the previous opinion on the 
single event MON 87705 (EFSA GMO Panel, 2012). Although high variability between-site was 
observed (Section 4.2.4), the fatty acid profile of soybean MON 87705 × MON 89788 seeds is similar 
as that of soybean MON 87705 seeds.
37
 The fatty acid profile of the RDB oil of the soybean MON 
87705  MON 89788 is essentially the same as that of the unprocessed seeds.38 Consequently, the 
EFSA GMO Panel concludes that the basis for the nutritional assessment made for soybean MON 
87705 can be used also for the soybean MON 87705 × MON 89788. 
The assessment of dietary exposure
39
 covers all possible uses of soybean MON 87705 × MON 89788 
oil, including both commercial and domestic uses as well as frying. Consumption data are taken from 
the UK National Diet and Nutrition Survey 2008-2010 (Bates et al., 2011). The estimated dietary 
intake (expressed as percentage of energy (E %) of the total diet) of fatty acid groups (saturated fatty 
acids (SFAs), monounsaturated fatty acids (MUFAs), n-3 polyunsaturated acids (PUFAs) and n-6 
PUFAs) was based on fatty acid composition
40
 of the unprocessed herbicide-treated soybean seeds 
MON 87705 × MON 89788,
41
 using three substitution levels (100 %, 50 % and 25 %) of vegetable 
oils
42
 with soybean MON 87705  MON 89788 oil. The EFSA GMO Panel selected the 100 % 
substitution as the most conservative scenario arising from both domestic and commercial use of the 
vegetable oils. 
Calculations based on the full replacement scenario indicated that fatty acid intakes would be closer to 
current dietary advice for MUFA and n-3 PUFA intake. 
Linoleic acid is the main dietary cis-n-6 PUFA. EFSA has proposed an Adequate Intake for linoleic 
acid of 4 E % (EFSA NDA Panel, 2010). The previous assessment showed that intakes of n-6 PUFA 
for adults (50
th
 and 97.5
th
 centile) would fall by around 40 %, but it was concluded this was unlikely to 
be of concern, because linoleic acid deficiency has not been observed at intakes > 1E % (EFSA NDA 
Panel, 2010) and because the 100 % replacement by soybean MON 87705 × MON 89788 oil of 
vegetable oils in the diet is unlikely to occur (EFSA GMO Panel, 2013). However, data on low 
consumers of vegetable oils (i.e., below the 5
th
 centile), who are potentially at the greatest risk of 
linoleic acid deficiency, were not available at that time. 
In the context of this application, an assessment was provided for the low (5
th
), average (50
th
) and high 
(95
th
) centile adults (Table 3).  
  
                                                     
37 Additional information: 24/10/2014 (Table 2). 
38 Additional information: 3/6/2015 (Table 1). 
39 Additional information: 12/5/2014 (Exponet, 2014). 
40 Dossier: Part II— Section A3.3; additional information: 18/9/2013 and 17/2/2014. 
41 These seeds are harvested from the field trial in USA in 2009. 
42 Conventional soybean, rapeseed and sunflower oils. These three oils account for about 80% of vegetable oils available for 
consumption in the UK. 
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Table 7:  Estimated daily intake (E %) of fatty acid groups before (B) and after (A) the replacement. 
Predicted changes in the total diet with respect to fatty acid groups (SFAs, MUFAs and PUFAs) are 
given as percentage of total energy in adults (19-64) years old for the 5
th
, 50
th
 and 95
th
 centile 
consumers through replacement of all consumed vegetable oils (soybean, rapeseed and sunflower) by 
soybean MON 87705 × MON 89788.  
Fatty 
acid 
group 
Males Females 
5
th
 %
(a)
 50
th
 %
(b)
 95
th
 %
(c)
 5
th
 %
(a)
 50
th
 %
(b)
 95
th
 %
(c)
 
B A B A B A B A B A B A 
SFA 6.6 5.1 12.4 9.3 18.7 14.4 7.1 5.1 12.3 9.3 19.0 15.0 
MUFA 7.1 9.7 11.8 16.1 16.5 22.6 7.0 9.6 11.7 16.0 16.0 21.8 
n-3 
PUFA  
0.5 0.6 0.9 1.0 1.8 2.1 0.5 0.6 0.9 1.0 1.9 2.2 
n-6 
PUFA  
2.4 1.7 4.7 3.4 7.3 5.3 2.7 1.9 4.6 3.4 7.8 5.7 
(a); see Table 8-B-1 in [Exponent 2014].  
(b): see Table 8-C-1 in [Exponent 2014].  
(c): see Table 8-D-1 in [Exponent 2014]. 43 
As Table 7 shows that although a decrease in the intake of n-6 PUFA occurs in both males and 
females, this would still result in intakes of > 1 E %, which is greater than the level below which 
symptoms of linoleic deficiency may occur.  
Although the dietary assessment considers only exposure of adults, the EFSA Dietary Reference 
Values report on fatty acids (EFSA NDA Panel, 2010) shows that intake data for n-6 PUFA for 
children from four European countries were similar to those of adults, therefore, the EFSA GMO 
Panel considers that the exposure assessment made in adults is valid also for children. 
In conclusion, the profile of fatty acid intake, after substituting soybean MON 87705 × MON 89788 
oil for conventional vegetable oils, is closer to current dietary advice for MUFA and n-3 PUFA intake. 
Although variability was observed in the fatty acid profile between-site (Section 4.2.1.4), only that 
affecting the linoleic acid content might give rise to concern, given the proximity of the intake values 
for low consumers (Table 7) to the level where symptoms of deficiency may occur. However, 
considering the conservative nature of the full replacement scenario in the exposure assessment, the 
magnitude of the differences observed would not be expected to introduce adverse effects on human 
health with respect to n-6 PUFA intake. This was demonstrated when partial replacement scenarios 
were considered. 
Other soybean products for human consumption are not expected to differ in their composition, except 
for their fatty acid content. The contribution of fatty acids from such products to overall human 
exposure would be small and is not expected to affect the conclusion on human health and nutrition. 
4.3.5.2. Animal nutritional assessment 
Defatted toasted soybean meal represents the most common soybean by-product used in animal feed 
formulations, with around 90 % of the defatted soybean meal entering the feed chain in the European 
Union mainly for poultry, pig and cattle. Presently, only small amounts of full fat soybeans (1 % of the 
total soybean feed) are directly fed to food-producing animals. The use of soybean oil in animal feed is 
limited and only small amounts (0.5-3 %) are added to mixed feed (especially for poultry and pigs) in 
order to avoid dust, improve the quality/stability of pellets and add energy to the diets.
44
 
Compositional data indicate that the defatted soybean meal from soybean MON 87705 × MON 89788 
would be expected to deliver the same nutrition as its comparator and other non-GM commercial 
                                                     
43 Additional information: 12/5/2014. 
44 Personal communication from Deutscher Verband für Tiernahrung, 29 July 2011 
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varieties. This was confirmed by results of a feeding study in chickens for fattening (see Section 
4.3.3). 
4.3.6. Post-market monitoring of GM food/feed 
A proposal for a post-market monitoring plan needs to be provided by the applicant (EFSA GMO 
Panel, 2011a). EFSA recommends that the post-market monitoring plan should initially focus on the 
collection of import data for Europe. In the event of significant import such that a new exposure 
assessment is required, consumption data for the European population and concentration data for fatty 
acids in the oils would be needed. 
For specific labelling, the applicant proposed that, for example, operators handling products 
containing or consisting of oil produced from soybean MON 87705 × MON 89788 shall be required to 
label these products with the words “increased oleic acid oil produced from genetically modified 
soybean”. The EFSA GMO Panel considers that this proposal is consistent with the compositional data 
of this soybean. 
4.3.7. Conclusion 
The safety assessment identified no concerns regarding the potential toxicity and allergenicity of the 
newly expressed CP4 EPSPS protein, and found no evidence that the genetic modification might 
significantly change the overall allergenicity of soybean MON 87705 × MON 89788. Nutritional 
assessment on soybean MON 87705 × MON 89788 oil and oil-containing food products did not 
identify concerns on human health and nutrition. There are no concerns regarding the use of 
feedingstuffs derived from defatted soybean meal MON 87705 × MON 89788. 
4.4. Environmental risk assessment and monitoring plan 
4.4.1. Evaluation of relevant scientific data 
Considering the scope of application EFSA-GMO-NL-2011-100, the environmental risk assessment 
(ERA) of the GM soybean is concerned mainly with: (1) the exposure of bacteria to recombinant DNA 
in the gastrointestinal tract of animals fed GM material and bacteria present in environments exposed 
to faecal material; and (2) the accidental release into the environment of viable seeds of soybean 
MON 87705  MON 89788 during transport and processing. 
As the scope of application EFSA-GMO-NL-2011-100 excludes cultivation, environmental concerns 
in the EU related to the use of glyphosate-based herbicides on the GM soybean do not apply. 
4.4.2. Environmental risk assessment 
4.4.2.1. Potential unintended effects on plant fitness due to the genetic modification45 
Cultivated soybean (Glycine max (L.) Merr.) is a species in the subgenus Soja of the genus Glycine. 
The species originated from eastern Asia and is a highly domesticated crop (Lu, 2005). The major 
worldwide soybean producers are Argentina, Brazil, China, North Korea, South Korea and the USA. 
In the EU,
46
 soybean is mainly cultivated in Italy, Romania, France, Hungary, Austria, Slovakia and 
the Czech Republic (Dorokhov et al., 2004; Krumphuber, 2008). Cultivated soybean seeds rarely 
display any dormancy characteristics and only under certain environmental conditions grow as 
volunteers in the year after cultivation. If volunteers occur, they do not compete well with the 
succeeding crop, and can easily be controlled mechanically or chemically (OECD, 2000). In soybean 
fields, seeds do not usually survive the winter owing to herbivory, rotting and germination resulting in 
death, or owing to management practices prior to planting the subsequent crop (Owen, 2005).  
                                                     
45 Dossier: Part II—Section E3.1 and Appendix D. 
46 http://epp.eurostat.ec.europa.eu/portal/page/portal/agriculture/data/database  
Scientific Opinion on GM soybean MON 87705 × MON 89788  
 
EFSA Journal 2015;13(7):4178 21 
The expected changes in seed fatty acid composition in soybean MON 87705 × MON 89788 resulting 
from the introduced FAD2-1A/FATB1-A suppression cassette are not known to provide an agronomic 
or selective advantages. The herbicide tolerance trait can be regarded as providing only potential 
agronomic and selective advantages for this GM soybean plant where and when glyphosate-based 
herbicides are applied. However, survival of soybean plants outside cultivation where glyphosate-
based herbicides are applied is limited, mainly by a combination of low competitiveness, absence of a 
dormancy phase, and susceptibility to plant pathogens and cold climatic conditions. Based on the 
inserted traits, the EFSA GMO Panel considers that these general characteristics are unchanged in 
soybean MON 87705 × MON 89788; herbicide tolerance is therefore unlikely to provide a selective 
advantage outside cultivation. Even if glyphosate-based herbicides are applied to these plants, this will 
not change their ability to survive over seasons. Therefore, it is considered very unlikely that soybean 
MON 87705 × MON 89788 will differ from conventional soybean varieties in its ability to survive 
until subsequent seasons or to establish feral populations under European environmental conditions. 
Laboratory tests and field studies have been carried out to assess the phenotypic and agronomic 
characteristics as well as the environmental interactions of GM soybean as described in 
Section 4.2.1.3. Phenotypic and agronomic characteristics were evaluated in a field trial across eight 
locations in the USA in 2009. In addition, environmental interactions, such as soybean 
MON 87705 × MON 89788 responses to abiotic and biotic stressors, were evaluated in the same trials 
(i.e. they were not treated with glyphosate-based herbicides; for further details, see Section 4.2.1.3). 
Considering the scope of application EFSA-GMO-NL-2011-100, special attention is paid to those 
agronomic characteristics that may affect the survival, establishment and fitness of soybean 
MON 87705 × MON 89788 grains which could be accidentally released into the environment: e.g. 
early and final stand count, plant vigour, 100-seed weight, plant height and yield. As described in 
Section 4.2.1.3, soybean MON 87705 × MON 89788 treated and not treated with glyphosate-based 
herbicides had a lower early stand count but a higher plant vigour than its non-GM comparator. 
Moreover, the equivalence test for the early stand count and plant vigour endpoints indicates that 
equivalence with non-GM reference varieties is more likely than not. For this reason and because these 
endpoints are relevant for the assessment of possible changes in persistence and invasiveness of the 
GM soybean, the significant differences observed in early stand count and plant vigour are further 
assessed below.  
During the ERA of the single soybean transformation event MON 87705 (EFSA GMO Panel, 2012), 
the EFSA GMO Panel also observed that “soybean MON 87705 had a lower early and final stand 
count and a lower 100-seed weight than its conventional counterpart”. The observed differences in 
early stand count and plant vigour for soybean MON 87705 × MON 89788 might therefore be an 
indication of unintended effects due to the genetic modification. Differences in seed lot quality could 
also explain such observations; however, the information included in the dossier does not indicate 
such an effect. 
Specific data on pollen viability, seed germination and dormancy for soybean 
MON 87705 × MON 89788 were not provided by the applicant. Therefore, the EFSA GMO Panel 
asked the applicant to clarify the origin and production conditions of the test materials used, and to 
justify that the best materials allowed a proper comparative assessment. The applicant did not provide 
additional data but did provide a rationale
47
 relying on seed germination data for the two single 
soybean events
48
 and data on the early stand count for soybean MON 87705 × MON 89788 compared 
with its comparator. The applicant concluded that “the use of MON 87705 × MON 89788 and control 
materials that had similar genetic backgrounds except for the traits of interest, and the seed 
germination characteristics already provided, demonstrate the suitability of the test and control 
materials utilized in the comparative assessment”.  
                                                     
47 Additional information: 08/05/2014. 
48 Section D.4 of EFSA-GMO-NL-2006-36 and Section D.4 of EFSA-GMO-NL-2010-78. 
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The EFSA GMO Panel therefore considered the data provided by the applicant on seed germination 
and dormancy of the single soybean events MON 87705 and MON 89788, their comparators and non-
GM reference varieties, produced under different environmental conditions (see EFSA, 2008; EFSA 
GMO Panel, 2012). For soybean MON 89788, there were no differences observed in seed germination 
compared with its conventional counterpart under all controlled environmental conditions. For 
soybean MON 87705, differences in seed germination were observed under certain controlled 
environmental conditions. The observed differences were not associated with the characteristics of the 
sites from which the seeds were obtained and did not indicate a consistent plant response associated 
with the herbicide-tolerant event.  
Considering the available dataset on soybean MON 87705 × MON 89788, and in the light of the scope 
of application EFSA-GMO-NL-2011-100, the EFSA GMO Panel did not expect changes in the seed 
germination characteristics of soybean MON 87705  MON 89788. 
Although the differences observed in early plant count and plant vigour might result from the genetic 
modification, they more likely indicate a decreased fitness of the GM soybean. The other 
characteristics of the GM soybean, relevant to persistence and invasiveness, are not changed. The 
EFSA GMO Panel therefore concludes that there is no indication of increased weediness potential of 
soybean MON 87705 × MON 89788 in the context of the scope of application EFSA-GMO-NL-2011-
100.  
Although the differences observed in early plant count and plant vigour might result from the genetic 
modification, they are unlikely to be biologically relevant in terms of increased weediness potential of 
soybean MON 87705 × MON 89788 in the context of the scope of application EFSA-GMO-NL-2011-
100 and considering that the other characteristics of soybean MON 87705 × MON 89788, relevant to 
persistence and invasiveness, are not changed. 
In addition to the data presented by the applicant, the EFSA GMO Panel is not aware of any scientific 
report of increased spread and establishment of existing GM soybeans and any change in the survival 
capacity, including overwintering (Dorokhov et al., 2004; Owen, 2005; Bagavathiannan and Van 
Acker, 2008; Lee et al., 2009).  
Therefore, the EFSA GMO Panel is of the opinion that the likelihood of unintended environmental 
effects of the soybean MON 87705 × MON 89788 in Europe will not be different from that of 
conventional soybean varieties. 
4.4.2.2. Potential for gene transfer49 
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic material, 
either through horizontal gene transfer (HGT) of DNA or through vertical gene flow via seed dispersal 
and cross-pollination. 
(a) Plant-to-bacteria gene transfer 
The potential for HGT of the recombinant DNA of the single events has already been assessed in 
previous opinions (EFSA, 2008; EFSA GMO Panel, 2012) and no concern for an unlikely, but 
theoretically possible, HGT of the recombinant genes to bacteria in the gut or other receiving 
environments was identified. 
Bioinformatic analyses revealed, for MON 87705, two left border sequences, one at the 5-end and one 
at the 3-end with perfect identity to the Agrobacterium tumefaciens Ti plasmid. The sequence 
between the borders of the plant insert has a length of 10 530 bp and carries a plant-codon optimized 
version of the epsps gene of Agrobacterium sp. CP4. The GMO panel assumes that the sequence 
identity of these two border sequences has the potential to facilitate double HR with Ti plasmids of 
                                                     
49 Dossier: Part II—Sections E3.1–3.2. 
Scientific Opinion on GM soybean MON 87705 × MON 89788  
 
EFSA Journal 2015;13(7):4178 23 
environmental A. tumefaciens strains, resulting in the insertion of this 10 530 bp DNA fragment. The 
large size of this insert, however, decreases the probability for HGT. Considering the presence of 
native bacterial epsps genes and the codon optimization of the CP4 epsps gene, its transfer would not 
confer a new trait to bacterial recipients present in receiving environments. Recipients receiving a Ti 
plasmid with such a large DNA insert would also, most likely, be affected in their fitness because of 
the additional burden of replicating non-functional DNA in their cells during growth.  
For the bioinformatic analyses of MON 89788, no sequence identity with bacterial DNA, including the 
CP4 epsps gene, which was plant codon optimized, were identified. Thus, there is no indication for 
facilitated gene transfer of recombinant DNA from MON 89788 to bacteria.  
Synergistic effects of the recombinant genes in increasing the likelihood for HGT, for instance 
combinations of recombinogenic sequences, were not identified. Since soybean 
MON 87705  MON 89788 is produced from conventional crossing, close linkage of the different 
events is extremely unlikely.  
Therefore, in line with its previous assessment of soybean, MON 87705 and MON 89788, and 
considering the new, additional bioinformatic analyses provided by the applicant, the EFSA GMO 
Panel concludes that in the context of its intended uses, the unlikely but theoretically possible transfer 
of the recombinant genes from soybean MON 87705  MON 89788 to environmental bacteria does 
not give rise to any safety concern. 
(b) Plant-to-plant gene transfer 
Considering the scope of application EFSA-GMO-NL-2011-100 and the physical characteristics of 
soybean seeds, a possible pathway of gene dispersal is from seed spillage and pollen of occasional 
feral GM soybean plants originating from accidental seed spillage during transport and/or processing. 
The genus Glycine is divided into two distinct subgenera: Glycine and Soja. Soybean is in the 
subgenus Soja. The subgenus Glycine contains 16 perennial wild species, while the cultivated 
soybean, G. max, and its wild and semi-wild annual relatives, G. soja and G. gracilis, are classified in 
the subgenus Soja (OECD, 2000). Owing to the low level of genomic similarity among species of the 
genus Glycine, G. max can cross only with other members of the Glycine subgenus Soja (Hymowitz et 
al., 1998; Lu, 2005). Hence, the three species of the subgenus Soja are capable of cross-pollination and 
the hybrid seed that is produced can germinate normally and produce plants with fertile pollen and 
seeds (Abe et al., 1999; Nakayama and Yamaguchi, 2002). However, since G. soja and G. gracilis are 
indigenous to China, Taiwan, Korea, Japan, the far-eastern region of Russia, Australia, the Philippines 
and the South Pacific, and since they have not been reported in other parts of the world where the 
cultivated soybean is grown (Dorokhov et al., 2004; Lu, 2005), the plant-to-plant gene transfer from 
soybean is restricted to cultivated areas and the occasional soybean plants resulting from seed spillage 
in the EU. 
Soybean is an annual almost completely self-pollinating crop in the field, which has a percentage of 
cross-pollination of usually less than 1 % (Weber and Hanson, 1961; Caviness, 1966; Ray et al., 2003; 
Lu, 2005; Yoshimura et al., 2006; Abud et al., 2007). Soybean pollen dispersal is limited because the 
anthers mature in the bud and directly pollinate the stigma of the same flower (OECD, 2000).  
However, cross-pollination rates as high as 6.3 % have been reported for closely spaced plants (Ray et 
al., 2003), suggesting the potential for some within-crop gene flow in soybean. These results indicate 
that natural cross-pollination rates can fluctuate significantly among different soybean varieties under 
particular environmental conditions such as favourable climate for pollination and an abundance of 
pollinators (Gumisiriza and Rubaihayo, 1978; Kikuchi et al., 1993; Ahrent and Caviness, 1994; Ray et 
al., 2003; Lu, 2005). 
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Plant-to-plant gene transfer could therefore occur under the following scenarios: imports of soybean 
MON 87705  MON 89788 seeds (although most MON 87705  MON 89788 grains will be 
processed in the countries of production), processing outside importing ports, transport in regions of 
soybean production in Europe, spillage of GM seeds during transport, germination and development of 
spilled seeds within soybean fields or in very close vicinity to cultivated soybean fields, overlap of 
flowering periods and environmental conditions favouring cross-pollination. The overall likelihood of 
cross-pollination between GM soybean plants and cultivated soybean is therefore extremely low. 
Apart from seed production areas, GM plants and plants derived from out-crossing with this GM 
soybean will not persist over time. Dispersal of soybean seeds by animals is not expected owing to the 
characteristics of the seed, but accidental release into the environment of seeds may occur during 
transport and processing for food, feed and industrial uses. However, cultivated soybean seeds rarely 
display any dormancy characteristics and only under certain environmental conditions grow as 
volunteers in the year after cultivation (OECD, 2000). Even in soybean fields, seeds do not usually 
survive the winter because of predation, rotting or germination resulting in death, or as a result of 
management practices prior to planting the subsequent crop (Owen, 2005). 
The EFSA GMO Panel takes into account that this application does not include cultivation of the 
soybean within the EU so that the likelihood of cross-pollination between cultivated soybean and 
occasional soybean plants resulting from seed spillage is considered extremely low. However, in 
countries cultivating this GM soybean and producing seed for export, there is a potential for admixture 
in seed production and thus the introduction of GM seeds through this route. Hence, it is important 
that appropriate management systems are in place to restrict seeds of soybean 
MON 87705  MON 89788 entering cultivation as this would require specific approval under 
Directive 2001/18/EC or Regulation (EC) No 1829/2003. 
In conclusion, as soybean MON 87705  MON 89788 has no altered survival, multiplication or 
dissemination characteristics, the EFSA GMO Panel is of the opinion that the likelihood of unintended 
environmental effects as a consequence of spread of genes from this GM soybean in Europe will not 
differ from that of conventional soybean varieties. 
4.4.2.3. Potential interactions of the GM plant with target organisms50 
Considering the scope of application EFSA-GMO-NL-2011-100, and in the absence of target 
organisms, potential interactions of the GM plant with target organisms were not considered a relevant 
issue by the EFSA GMO Panel. 
4.4.2.4. Potential interactions of the GM plant with non-target organisms51 
Considering the scope of application EFSA-GMO-NL-2011-100, and the low level of exposure to the 
environment, potential interactions of the GM plant with non-target organisms were not considered a 
relevant issue by the EFSA GMO Panel. 
4.4.2.5. Potential interactions with the abiotic environment and biogeochemical cycles52 
Considering the scope of application EFSA-GMO-NL-2011-100, and the low level of exposure to the 
environment, potential interactions with the abiotic environment and biogeochemical cycles were not 
considered a relevant issue by the EFSA GMO Panel. 
4.4.3. Post-market environmental monitoring53 
The objectives of a post-market environmental monitoring (PMEM) plan, according to Annex VII of 
Directive 2001/18/EC, are (1) to confirm that any assumption regarding the occurrence and impact of 
potential adverse effects of the GMO, or its use, in the ERA are correct; and (2) to identify the 
                                                     
50 Dossier: Part II—Section E3.3. 
51 Dossier: Part II—Section E3.4. 
52 Dossier: Part II—Section E3.6. 
53 Dossier: Part II—Section E4. 
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occurrence of adverse effects of the GMO, or its use, on human health or the environment that were 
not anticipated in the ERA. 
Monitoring is related to risk management, and thus a final adoption of the PMEM plan falls outside 
the mandate of EFSA. However, the EFSA GMO Panel gives its opinion on the scientific content of 
the PMEM plan provided by the applicant (EFSA, 2006; EFSA GMO Panel, 2011b). The potential 
exposure to the environment of soybean MON 87705 × MON 89788 would be through faecal material 
from animals fed the GM soybean or through accidental release into the environment of GM soybean 
seeds during transport and processing. The EFSA GMO Panel is aware that, owing to the physical 
characteristics of soybean seeds and the methods of transport used, accidental spillage cannot be 
excluded. Hence, it is important that appropriate management systems are in place to restrict seeds of 
soybean MON 87705 × MON 89788 entering cultivation, as this would require specific approval 
under Directive 2001/18/EC or Regulation (EC) No 1829/2003. 
The PMEM plan proposed by the applicant includes (1) the description of an approach involving 
operators (federations involved in soybean import and processing) reporting to the applicant via a 
centralised system any observed adverse effect(s) of GMOs on human health and the environment; 
(2) a coordinating system established by EuropaBio for the collection of the information recorded by 
the various operators; and (3) the use of networks of existing surveillance systems (Lecoq et al., 2007; 
Windels et al., 2008). The applicant proposes to submit a PMEM report on an annual basis and a final 
report at the end of the consent. 
The EFSA GMO Panel is of the opinion that the PMEM plan proposed by the applicant is in line with 
the scope of application EFSA-GMO-NL-2011-100, as the ERA did not cover cultivation and 
identified no potential adverse environmental effects. No case-specific monitoring is necessary. The 
EFSA GMO Panel agrees with the reporting intervals proposed by the applicant in its PMEM plan. 
4.4.4. Conclusion 
Considering the scope of application EFSA-GMO-NL-2011-100, there are no indications of an 
increased likelihood of establishment and spread of feral soybean MON 87705 × MON 89788 plants 
in the event of accidental release into the environment of viable GM soybean seeds. Potential 
interactions of soybean MON 87705 × MON 89788 with the biotic and abiotic environment were not 
considered a relevant issue by the EFSA GMO Panel. The unlikely but theoretically possible transfer 
of the recombinant genes from soybean MON 87705 × MON 89788 to environmental bacteria does 
not give rise to a safety concern owing to the lack of a selective advantage in the context of its 
intended uses. The PMEM plan provided by the applicant and the reporting intervals are in line with 
the scope of application EFSA-GMO-NL-2011-100. 
CONCLUSIONS AND RECOMMENDATIONS 
No new data on the single soybean events MON 87705 and MON 89788 that would lead to a 
modification of the original conclusions on their safety were identified. 
The combination of soybean single events MON 87705 and MON 89788 in the two-event stack 
soybean MON 87705 × MON 89788 did not give rise to issues—relating to molecular, agronomic, 
phenotypic or compositional characteristics—regarding food and feed safety. The EFSA GMO Panel 
considers that there is no reason to expect interactions that could impact on the food and feed safety or 
nutritional properties.  
No differences in composition requiring further assessment for food/feed safety were observed 
between soybean MON 87705 × MON 89788 and its comparator, except for the intended trait i.e. 
altered fatty acid profile. Nutritional assessment on soybean MON 87705 × MON 89788 oil and oil-
containing food products did not identify concerns on human health and nutrition. There are no 
concerns regarding the use of feedingstuffs derived from defatted soybean meal MON 87705 × MON 
89788. The EFSA GMO Panel is of the opinion that soybean MON 87705 × MON 89788 is as safe, 
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and at least as nutritious, as its comparator and commercial soybean varieties, in the context of the 
scope of application EFSA-GMO-NL-2011-100.  
Considering the scope of application EFSA-GMO-NL-2011-100, there are no indications of an 
increased likelihood of establishment and spread of feral soybean MON 87705 × MON 89788 plants 
in the case of accidental release into the environment of viable GM soybean seeds. Potential 
interactions of soybean MON 87705 × MON 89788 with the biotic and abiotic environment were not 
considered a relevant issue by the EFSA GMO Panel. The unlikely but theoretically possible transfer 
of the recombinant genes from soybean MON 87705 × MON 89788 to environmental bacteria does 
not give rise to any safety concern owing to the lack of a selective advantage in the context of its 
intended uses. The PMEM plan provided by the applicant and the reporting intervals are in line with 
the scope of application EFSA-GMO-NL-2011-100. 
In conclusion, the EFSA GMO Panel considers that the information available for soybean 
MON 87705 × MON 89788 addresses the scientific comments raised by Member States and that 
soybean MON 87705 × MON 89788, as described in this application, is as safe as its non-GM 
comparator and the non-GM soybean reference varieties with respect to potential effects on human 
and animal health and the environment in the context of the scope of the application. 
Considering the modified composition and nutritional values of soybean MON 87705 × MON 89788, 
the EFSA GMO Panel agrees with the specific labelling proposal provided by the applicant, in 
accordance with Articles 13(2)(a) and 25(2)(c) of Regulation (EC) No 1829/2003.
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DOCUMENTATION PROVIDED TO EFSA 
1. Letter from the Competent Authority of the Netherlands, received on 17 August 2011 
concerning a request for authorisation for placing on the market of genetically modified soybean 
MON 87705 × MON 89788 submitted under Regulation (EC) No 1829/2003 by Monsanto 
Europe S.A./N.V. (application reference EFSA-GMO-NL-2011-100) 
2. Acknowledgement letter dated 5 September 2011 from EFSA to the Competent Authority of the 
Netherlands. 
3. Letter from EFSA to applicant dated 27 September 2011 requesting additional information 
under completeness check.  
4. Letter from applicant to EFSA received on 1 June 2012 providing additional information under 
completeness check.  
5. Letter from EFSA to applicant dated 22 June 2012 requesting additional information under 
completeness check.  
6. Letter from applicant to EFSA received on 9 July 2012 providing additional information under 
completeness check.  
7. Letter from EFSA to applicant dated 1 August 2012 (effective from 30 July 2012) delivering the 
“Statement of Validity” of the application for the placing on the market of genetically modified 
soybean MON 87705 × MON 89788 (EFSA-GMO-NL-2011-100) submitted in accordance with 
Regulation (EC) No 1829/2003 Monsanto Europe S.A./N.V. 
8. Letter from EFSA to applicant dated 2 August 2012 stopping the clock due to the on-going risk 
assessment of the single event MON 87705 (application EFSA-GMO-NL-2010-78). 
9. Letter EFSA to applicant dated 9 October 2012 re-starting the clock due to the finalisation of 
the risk assessment of the single event MON 87705 (application EFSA-GMO-NL-2010-78). 
10. Letter from EFSA to applicant dated 11 February 2013 requesting additional information and 
stopping the clock. 
11. Letter from applicant to EFSA received on 22 February 2013 providing additional information. 
12. Letter from EFSA to applicant dated 10 April 2013 requesting additional information and 
maintaining the clock stopped. 
13. Letter from EFSA to applicant dated 11 April 2013 requesting additional information and 
maintaining the clock stopped. 
14. Letter from applicant to EFSA received on 22 May 2013 providing additional information. 
15. Letter from EFSA to applicant dated 27 June 2013 requesting additional information and 
maintaining the clock stopped. 
16. Letter from applicant to EFSA received on 2 July 2013 providing additional information. 
17. Letter from applicant to EFSA received on 7 August 2013 providing additional information. 
18. Letter from EFSA to applicant dated 5 September 2013 requesting additional information and 
maintaining the clock stopped. 
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19. Letter from applicant to EFSA received on 18 September 2013 providing additional 
information. 
20. Letter from EFSA to applicant dated 29 November 2013 requesting additional information and 
maintaining the clock stopped. 
21. Letter from applicant to EFSA received on 17 February 2014 providing additional information. 
22. Letter from EFSA to applicant dated 19 February 2014 requesting additional information and 
maintaining the clock stopped. 
23. Letter from applicant to EFSA received on 12 May 2014 providing additional information. 
24. Letter from EFSA to applicant dated 25 July 2014 requesting additional information and 
maintaining the clock stopped. 
25. Letter from applicant to EFSA received on 24 October 2014 providing additional information. 
26. Letter from EFSA to applicant dated 27 November 2014 requesting additional information and 
maintaining the clock stopped. 
27. Letter from EFSA to applicant dated 27 February 2015 requesting additional information and 
maintaining the clock stopped. 
28. Letter from applicant to EFSA received on 9 April 2015 providing additional information. 
29. Letter from applicant to EFSA received on 1 June 2015 providing additional information. 
30. Letter from EFSA to applicant dated 15 June 2015 re-starting the clock. 
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